paroxetine has been researched along with pituitrin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayonrinde, OT; Sanfilippo, FM | 1 |
| Chiu, HF; Lam, LC; Leung, VP | 1 |
| Domingo, P; Monmany, J; Rodríguez, J; Vázquez, G | 1 |
| Holsboer, F; Keck, ME; Landgraf, R; Müller, MB; Ohl, F; Toschi, N; Uhr, M; Welt, T; Wigger, A | 1 |
| Amico, JA; Fabian, TJ; Kroboth, PD; Mulsant, BH; Pollock, BG; Reynolds, CF | 1 |
| Amico, JA; Begley, AE; Bensasi, SG; Corey, SE; Dew, MA; Fabian, TJ; Kroboth, PD; Mulsant, BH; Pollock, BG; Reynolds, CF; Weber, E | 1 |
| Kubota, T; Miyata, A | 1 |
1 trial(s) available for paroxetine and pituitrin
| Article | Year |
|---|---|
Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Topics: Aged; Depressive Disorder, Major; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Paroxetine; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Vasopressins | 2003 |
6 other study(ies) available for paroxetine and pituitrin
| Article | Year |
|---|---|
SSRI antidepressants and SIADH.
Topics: Aged; Female; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Vasopressins | 1997 |
Hyponatremia associated with paroxetine.
Topics: Aged; Depressive Disorder; Female; Humans; Hyponatremia; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sodium; Vasopressins | 1998 |
Syndrome of inappropriate secretion of antidiuretic hormone induced by paroxetine.
Topics: Aged; Antidepressive Agents, Second-Generation; Humans; Inappropriate ADH Syndrome; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Vasopressins | 1999 |
Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model.
Topics: Animals; Anxiety Disorders; Disease Models, Animal; Hypothalamus; Male; Neurosecretory Systems; Paroxetine; Rats; RNA, Messenger; Species Specificity; Vasopressins | 2003 |
Paroxetine-induced hyponatremia in older adults: a 12-week prospective study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Biomarkers; Blood Glucose; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Incidence; Male; Middle Aged; Natriuresis; Osmolar Concentration; Paroxetine; Pennsylvania; Prospective Studies; Regression Analysis; Risk Factors; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sodium; Statistics as Topic; Treatment Failure; Vasopressins | 2004 |
Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine.
Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Electrolytes; Humans; Hyponatremia; Inappropriate ADH Syndrome; Intervertebral Disc Displacement; Male; Pain; Paroxetine; Sodium; Spinal Stenosis; Vasopressins | 2006 |